🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fabrice Smieliauskas

Wayne State University

ORCID: 0000-0002-9466-9308
Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)”.

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)

The Oncologist(2023)10.1093/oncolo/oyad140
N/A
0.229DataRank · unranked
3 citations

Jennifer Le‐Rademacher, Fabrice Smieliauskas, Kathryn J. Ruddy, Thomas J. Saphner, Heshan Liu +10 more

Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, double-blind, placebo-controlled trial (ALLIANCE A221602).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12107
N/A
0DataRank · unranked
1 citations

Jennifer Le‐Rademacher, Fabrice Smieliauskas, Kathryn J. Ruddy, Thomas J. Saphner, Heshan Liu +9 more

Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey

JCO Oncology Practice(2023)10.1200/op.23.00159
N/A
0DataRank · unranked
11 citations

Rebecca A. Snyder, Danea Horn, Matthew F. Hudson, Anne Barber, Fabrice Smieliauskas +4 more